Cannabis Pharm ApS — Credit Rating and Financial Key Figures

Cannabis Pharm ApS (CVR number: 41811269) is a company from RANDERS. The company reported a net sales of 0.2 mDKK in 2023. The operating profit percentage was at 8.1 % (EBIT: 0 mDKK), while net earnings were 16.6 kDKK. The profitability of the company measured by Return on Assets (ROA) was 5 %, which can be considered decent but Return on Equity (ROE) was 99.2 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 2.1 %, a level that can be considered to be very low. This means the company is highly leveraged, with most assets financed through debt. This high level of financial risk could pose challenges in periods of financial distress or rising interest rates. Cannabis Pharm ApS's liquidity measured by quick ratio was 0.9 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.